Diagnosis

Anemia

A decrease in red blood cell mass leading to reduction in hemoglobin, hematocrit or RBC count:

  • Male: Hb < 13.5

  • Female: Hb < 12

  • Childre: Hb < 11

NB! Hemoglobin is a concentration --> affected by changes in plasma volume.

Etiology

Etiology of decreased production [2kz]

  1. Hypoproliferative Microcytic Anemia (corrected reticulocyte <2%, MCV<80)

    • Iron deficiency anemia / Malnutrition

    • Anemia of chronic disease (inflammatory inhibition through cytokines)

    • Sideroblastic anemia

    • Thalassemia

    • Lead poisoning 

  2. Hypoproliferative Normocytic Anemia (corrected reticulocyte <2%, MCV 80-100)

    • Anemia of chronic disease (inflammatory inhibition through cytokines)

    • Renal failure (low on EPO stimuli)

    • Bone marrow failure (Leukemia, Lymphoma, Myelofibrosis, Myelodysplasia, Aplasia)

    • Pure red cell aplasia

    • Myelofibrosis or myelophthisic processes

    • Multiple myeloma

  3. Hypoproliferative Macrocytic Anemia (corrected reticulocyte <2%, MCV>100)

    • Alcohol

    • Liver disease

    • Hypothyroidism (low on thyroxin stimuli)

    • Folate and Vitamin B12 deficiency

    • Myelodysplastic syndrome

    • Drug-induced

      • Diuretics 

      • Chemotherapeutic agents

      • Hypoglycemic agents

      • Antiretroviral agents

      • Antimicrobials

      • Anticonvulsants

Etiology of hemolytic anemia [2kz]

reticulocyte count is > 2%, elevated LD, decreased haptoglobin

Physical etiologies

Infectious etiologies

Genetic etiologies

Pathophysiology

Epidemiology

Incidence per 100.000 [4ce]

Epidemiology chart for Incidence

Prevalence per 100.000 [4ce]

Epidemiology chart for Prevalence

Approach

  1. Blood test: MCV, Ferritin, B12, Folic acid, Lactic dehydrogenase, Haptoglobin [2kz]

  2. Corrected reticulocyte count = percent reticulocytes x (patient's HCT/normal HCT)

    • If > 2: hemolysis or acute blood loss

    • If < 2: hypoproliferation

  3. MCV:

    • MCV <80

    • MCV 90-100

    • MCV >100

  4. Other tests based on reticulocytes and MCV:

    • Hemofec

    • Urine stix: hematuria

    • Coombs test

    • Blood smear

    • Coloscopy in elders

Treatment

  1. Acute treatment of anemia:

    • IV fluids, crossmatched blood transfusions, oxygen

    • Maintain hemoglobin > 7 g/dL (> 8 g/dL if cardiovascular disease)

  2. Treatment of the underlying cause

    • Nutritional deficiencies: Oral/IV iron, B12, and folate

    • Chronic disease

    • Hemolytic anemia: mechanical valve replacement, discontinue medication, splenectomy, exchange transfusions (hemoglobinopathies), antifibrinolytic agents (DIC)

Differential diagnoses

Aplastic anemia, Colorectal cancer, Folic acid deficiency, Hemolytic anemia, Hypothyroidism, Hypovolemia, Paroxysmal nocturnal hemoglobinuria, Shock, Sickle cell disease, Systemic lupus erythematosus, Thalassemia, Vitamin B12 deficiency


References

[1] Turner J, Parsi M, Badireddy M. Anemia. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499994/

[2] Levi et al. Epidemiology of iron deficiency anaemia in four European countries: a population-based study in primary care. Eur J Haematol. 2016 Dec;97(6):583-593.

[3] http://emedicine.medscape.com/article/198475 (2014-02-05); [Medscape]

[4] Tettamanti et al. Prevalence, incidence and types of mild anemia in the elderly: the "Health and Anemia" population-based study. Haematologica. 2010 Nov;95(11):1849-56.

[5] Stauder R, Thein SL. Anemia in the elderly: clinical implications and new therapeutic concepts. Haematologica. 2014 Jul;99(7):1127-30. doi: 10.3324/haematol.2014.109967.

[6] Akbarpour et al. Anemia prevalence, severity, types, and correlates among adult women and men in a multiethnic Iranian population: the Khuzestan Comprehensive Health Study (KCHS). BMC Public Health. 2022 Jan 25;22(1):168

Scroll to top